Molecular Genetics and New Medication Strategies for Opioid Addiction.

doi:10.1176/appi.ajp.2018.18030352

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Molecular Genetics and New Medication Strategies for Opioid Addiction.

The American journal of psychiatry - 1 Oct 2018

Hurd Yasmin L, O'Brien Charles P

Abstract excerpt

The opioid epidemic is at the epicenter of the drug crisis, resulting in an inconceivable number of overdose deaths and exorbitant associated medical costs that have crippled many communities across the socioeconomic spectrum in the United States. Classic medications for the treatment of opioid use disorder predominantly target the opioid system and thus have been underutilized, in part due to their own potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Epigenesis, Genetic
Share to Genetic Predisposition to Disease
Share to Opioid-Related Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 30068261
DOI: 10.1176/appi.ajp.2018.18030352
PMCID: PMC6167195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pharmacogenomic Variants

Share to Receptors, Opioid, mu

Share to Vaccines